{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T14:44:25Z","timestamp":1786373065699,"version":"build-2736575974"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T00:00:00Z","timestamp":1704153600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T00:00:00Z","timestamp":1704153600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Arch Psychiatry Clin Neurosci"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s00406-023-01729-0","type":"journal-article","created":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T16:03:58Z","timestamp":1704211438000},"page":"141-162","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Vaccination and clozapine use: a systematic review and an analysis of the VAERS database"],"prefix":"10.1007","volume":"275","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4199-5422","authenticated-orcid":false,"given":"Aslihan","family":"Aksar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justina","family":"Lutz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Strube","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jurjen J.","family":"Luykx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alkomiet","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,2]]},"reference":[{"key":"1729_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1185\/03007999709113338","volume":"14","author":"HY Meltzer","year":"1997","unstructured":"Meltzer HY (1997) Treatment-resistant schizophrenia\u2014the role of clozapine. Curr Med Res Opin 14:1\u201320. https:\/\/doi.org\/10.1185\/03007999709113338","journal-title":"Curr Med Res Opin"},{"key":"1729_CR2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.2023.27","author":"K Northwood","year":"2023","unstructured":"Northwood K, Pearson E, Arnautovska U et al (2023) Optimising plasma clozapine levels to improve treatment response: an individual patient data meta-analysis and receiver operating characteristic curve analysis. Br J Psychiatry. https:\/\/doi.org\/10.1192\/bjp.2023.27","journal-title":"Br J Psychiatry"},{"key":"1729_CR3","doi-asserted-by":"publisher","first-page":"359","DOI":"10.2165\/00003088-200746050-00001","volume":"46","author":"MC Mauri","year":"2007","unstructured":"Mauri MC, Volonteri LS, Colasanti A et al (2007) Clinical pharmacokinetics of atypical antipsychotics: a critical review of the relationship between plasma concentrations and clinical response. Clin Pharmacokinet 46:359\u2013388. https:\/\/doi.org\/10.2165\/00003088-200746050-00001","journal-title":"Clin Pharmacokinet"},{"key":"1729_CR4","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1111\/acps.13228","volume":"142","author":"E Wagner","year":"2020","unstructured":"Wagner E, McMahon L, Falkai P et al (2020) Impact of smoking behavior on clozapine blood levels\u2014a systematic review and meta-analysis. Acta Psychiatr Scand 142:456\u2013466. https:\/\/doi.org\/10.1111\/acps.13228","journal-title":"Acta Psychiatr Scand"},{"key":"1729_CR5","doi-asserted-by":"publisher","first-page":"4","DOI":"10.4103\/IJPSYM.IJPSYM_379_19","volume":"42","author":"J de Leon","year":"2020","unstructured":"de Leon J, Rajkumar AP, Kaithi AR et al (2020) Do Asian patients require only half of the clozapine dose prescribed for caucasians? A critical overview. Indian J Psychol Med 42:4\u201310. https:\/\/doi.org\/10.4103\/IJPSYM.IJPSYM_379_19","journal-title":"Indian J Psychol Med"},{"key":"1729_CR6","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/acps.12794","volume":"136","author":"I Castberg","year":"2017","unstructured":"Castberg I, Westin AA, Skogvoll E, Spigset O (2017) Effects of age and gender on the serum levels of clozapine, olanzapine, risperidone, and quetiapine. Acta Psychiatr Scand 136:455\u2013464. https:\/\/doi.org\/10.1111\/acps.12794","journal-title":"Acta Psychiatr Scand"},{"key":"1729_CR7","doi-asserted-by":"publisher","first-page":"127","DOI":"10.2165\/00003088-200039020-00004","volume":"39","author":"JA Carrillo","year":"2000","unstructured":"Carrillo JA, Benitez J (2000) Clinically significant pharmacokinetic interactions between dietary caffeine and medications. Clin Pharmacokinet 39:127\u2013153. https:\/\/doi.org\/10.2165\/00003088-200039020-00004","journal-title":"Clin Pharmacokinet"},{"key":"1729_CR8","doi-asserted-by":"publisher","first-page":"410","DOI":"10.2174\/138920008784746373","volume":"9","author":"L Urichuk","year":"2008","unstructured":"Urichuk L, Prior T, Dursun S, Baker G (2008) Metabolism of atypical antipsychotics: involvement of cytochrome P450 enzymes and relevance for drug-drug interactions. CDM 9:410\u2013418. https:\/\/doi.org\/10.2174\/138920008784746373","journal-title":"CDM"},{"key":"1729_CR9","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.schres.2017.03.045","volume":"192","author":"SR Clark","year":"2018","unstructured":"Clark SR, Warren NS, Kim G et al (2018) Elevated clozapine levels associated with infection: a systematic review. Schizophr Res 192:50\u201356. https:\/\/doi.org\/10.1016\/j.schres.2017.03.045","journal-title":"Schizophr Res"},{"key":"1729_CR10","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/wps.20806","volume":"20","author":"Q Wang","year":"2021","unstructured":"Wang Q, Xu R, Volkow ND (2021) Increased risk of COVID -19 infection and mortality in people with mental disorders: analysis from electronic health records in the United States. World Psychiatry 20:124\u2013130. https:\/\/doi.org\/10.1002\/wps.20806","journal-title":"World Psychiatry"},{"key":"1729_CR11","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1192\/bjp.2020.251","volume":"218","author":"H-L Jeon","year":"2021","unstructured":"Jeon H-L, Kwon JS, Park S-H, Shin J-Y (2021) Association of mental disorders with SARS-CoV-2 infection and severe health outcomes: nationwide cohort study. Br J Psychiatry 218:344\u2013351. https:\/\/doi.org\/10.1192\/bjp.2020.251","journal-title":"Br J Psychiatry"},{"key":"1729_CR12","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1093\/schbul\/sbab012","volume":"47","author":"D Tzur Bitan","year":"2021","unstructured":"Tzur Bitan D, Krieger I, Kridin K et al (2021) COVID-19 prevalence and mortality among schizophrenia patients: a large-scale retrospective cohort study. Schizophr Bull 47:1211\u20131217. https:\/\/doi.org\/10.1093\/schbul\/sbab012","journal-title":"Schizophr Bull"},{"key":"1729_CR13","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1097\/ACI.0000000000000592","volume":"19","author":"MJ Ponsford","year":"2019","unstructured":"Ponsford MJ, Pecoraro A, Jolles S (2019) Clozapine-associated secondary antibody deficiency. Curr Opin Allergy Clin Immunol 19:553\u2013562. https:\/\/doi.org\/10.1097\/ACI.0000000000000592","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"1729_CR14","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1192\/bjp.2020.151","volume":"219","author":"R Govind","year":"2021","unstructured":"Govind R, Fonseca de Freitas D, Pritchard M et al (2021) Clozapine treatment and risk of COVID-19 infection: retrospective cohort study. Br J Psychiatry 219:368\u2013374. https:\/\/doi.org\/10.1192\/bjp.2020.151","journal-title":"Br J Psychiatry"},{"key":"1729_CR15","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1192\/bjp.2018.152","volume":"214","author":"M Ponsford","year":"2019","unstructured":"Ponsford M, Castle D, Tahir T et al (2019) Clozapine is associated with secondary antibody deficiency. Br J Psychiatry 214:83\u201389. https:\/\/doi.org\/10.1192\/bjp.2018.152","journal-title":"Br J Psychiatry"},{"key":"1729_CR16","doi-asserted-by":"publisher","first-page":"204512532092816","DOI":"10.1177\/2045125320928167","volume":"10","author":"S Gee","year":"2020","unstructured":"Gee S, Gaughran F, MacCabe J et al (2020) Management of clozapine treatment during the COVID-19 pandemic. Therap Adv Psychopharmacol 10:204512532092816. https:\/\/doi.org\/10.1177\/2045125320928167","journal-title":"Therap Adv Psychopharmacol"},{"key":"1729_CR17","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.14441","author":"\u0130 Bayraktar","year":"2021","unstructured":"Bayraktar \u0130, Yal\u00e7\u0131n N, Demirkan K (2021) The potential interaction between COVID-19 vaccines and clozapine: a novel approach for clinical trials. Int J Clin Pract. https:\/\/doi.org\/10.1111\/ijcp.14441","journal-title":"Int J Clin Pract"},{"key":"1729_CR18","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbad030","author":"E Wagner","year":"2023","unstructured":"Wagner E, Siskind D, Falkai P et al (2023) Clozapine optimization: a delphi consensus guideline from the treatment response and resistance in psychosis working group. Schizophrenia Bull. https:\/\/doi.org\/10.1093\/schbul\/sbad030","journal-title":"Schizophrenia Bull"},{"key":"1729_CR19","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1007\/s40264-015-0330-8","volume":"38","author":"P Pellegrino","year":"2015","unstructured":"Pellegrino P, Perrotta C, Clementi E, Radice S (2015) Vaccine-drug interactions: cytokines, cytochromes, and molecular mechanisms. Drug Saf 38:781\u2013787. https:\/\/doi.org\/10.1007\/s40264-015-0330-8","journal-title":"Drug Saf"},{"key":"1729_CR20","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1177\/106002808401800904","volume":"18","author":"PF D\u2019Arcy","year":"1984","unstructured":"D\u2019Arcy PF (1984) Vaccine-drug interactions. Drug Intell Clin Pharm 18:697\u2013700. https:\/\/doi.org\/10.1177\/106002808401800904","journal-title":"Drug Intell Clin Pharm"},{"key":"1729_CR21","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1056\/NEJM198111193052106","volume":"305","author":"P Kramer","year":"1981","unstructured":"Kramer P, McClain CJ (1981) Depression of aminopyrine metabolism by influenza vaccination. N Engl J Med 305:1262\u20131264. https:\/\/doi.org\/10.1056\/NEJM198111193052106","journal-title":"N Engl J Med"},{"key":"1729_CR22","first-page":"470","volume":"126","author":"RS Goldstein","year":"1982","unstructured":"Goldstein RS, Cheung OT, Seguin R et al (1982) Decreased elimination of theophylline after influenza vaccination. Can Med Assoc J 126:470","journal-title":"Can Med Assoc J"},{"key":"1729_CR23","first-page":"288","volume":"123","author":"KW Renton","year":"1980","unstructured":"Renton KW, Gray JD, Hall RI (1980) Decreased elimination of theophylline after influenza vaccination. Can Med Assoc J 123:288\u2013290","journal-title":"Can Med Assoc J"},{"key":"1729_CR24","doi-asserted-by":"publisher","first-page":"4730","DOI":"10.1016\/j.vaccine.2014.06.068","volume":"32","author":"P Pellegrino","year":"2014","unstructured":"Pellegrino P, Carnovale C, Perrone V et al (2014) Efficacy of vaccination against influenza in patients with multiple sclerosis: the role of concomitant therapies. Vaccine 32:4730\u20134735. https:\/\/doi.org\/10.1016\/j.vaccine.2014.06.068","journal-title":"Vaccine"},{"key":"1729_CR25","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1053\/j.semarthrit.2003.10.003","volume":"33","author":"O Elkayam","year":"2004","unstructured":"Elkayam O (2004) The Effect of tumor necrosis factor blockade on the response to pneumococcal vaccination in patients with rheumatoid arthritis and ankylosing spondylitis. Semin Arthritis Rheum 33:283\u2013288. https:\/\/doi.org\/10.1053\/j.semarthrit.2003.10.003","journal-title":"Semin Arthritis Rheum"},{"key":"1729_CR26","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1136\/ard.2005.036434","volume":"65","author":"I Fomin","year":"2006","unstructured":"Fomin I (2006) Vaccination against influenza in rheumatoid arthritis: the effect of disease modifying drugs, including TNF blockers. Ann Rheum Dis 65:191\u2013194. https:\/\/doi.org\/10.1136\/ard.2005.036434","journal-title":"Ann Rheum Dis"},{"key":"1729_CR27","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1093\/rheumatology\/kei193","volume":"45","author":"MC Kapetanovic","year":"2006","unstructured":"Kapetanovic MC, Saxne T, Sj\u00f6holm A et al (2006) Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis. Rheumatology 45:106\u2013111. https:\/\/doi.org\/10.1093\/rheumatology\/kei193","journal-title":"Rheumatology"},{"key":"1729_CR28","doi-asserted-by":"publisher","DOI":"10.1136\/gpsych-2019-100183","volume":"33","author":"J de Leon","year":"2020","unstructured":"de Leon J, Ruan C-J, Verdoux H, Wang C (2020) Clozapine is strongly associated with the risk of pneumonia and inflammation. Gen Psych 33:e100183. https:\/\/doi.org\/10.1136\/gpsych-2019-100183","journal-title":"Gen Psych"},{"key":"1729_CR29","doi-asserted-by":"publisher","first-page":"686","DOI":"10.3109\/08923973.2011.651535","volume":"34","author":"M-L Chen","year":"2012","unstructured":"Chen M-L, Tsai T-C, Wang L-K et al (2012) Clozapine inhibits Th1 cell differentiation and causes the suppression of IFN-\u03b3 production in peripheral blood mononuclear cells. Immunopharmacol Immunotoxicol 34:686\u2013694. https:\/\/doi.org\/10.3109\/08923973.2011.651535","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"1729_CR30","unstructured":"Vaccine Adverse Event Reporting System (VAERS) Available online: https:\/\/vaers.hhs.gov\/index.html (Accessed on 8 January 2023)."},{"key":"1729_CR31","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. https:\/\/doi.org\/10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"1729_CR32","unstructured":"Harbour RT, Forsyth L (2008) SIGN 50: a guideline developer\u2019s Handbook; Rev. ed.; Scottish Intercollegiate Guidelines Network: Ediburgh (ISBN 978-1-905813-25-4)"},{"key":"1729_CR33","unstructured":"Ontobee: OAE Available online: https:\/\/ontobee.org\/ontology\/OAE (Accessed on 8 January 2023)"},{"key":"1729_CR34","unstructured":"MediQ-Startseite Available online: https:\/\/www.mediq.ch\/ (Accessed on 8 January 2023)"},{"key":"1729_CR35","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1345\/aph.1H423","volume":"41","author":"JR Horn","year":"2007","unstructured":"Horn JR, Hansten PD, Chan L-N (2007) Proposal for a new tool to evaluate drug interaction cases. Ann Pharmacother 41:674\u2013680. https:\/\/doi.org\/10.1345\/aph.1H423","journal-title":"Ann Pharmacother"},{"key":"1729_CR36","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1111\/acps.13428","volume":"146","author":"SRT Veerman","year":"2022","unstructured":"Veerman SRT, Moscou T, Bogers JPAM et al (2022) Clozapine and COVID-19 Vaccination: effects on blood levels and leukocytes. An observational cohort study. Acta Psychiatr Scand 146:168\u2013178. https:\/\/doi.org\/10.1111\/acps.13428","journal-title":"Acta Psychiatr Scand"},{"key":"1729_CR37","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1136\/jclinpath-2019-206235","volume":"73","author":"MJ Ponsford","year":"2020","unstructured":"Ponsford MJ, Steven R, Bramhall K et al (2020) Clinical and laboratory characteristics of clozapine-treated patients with schizophrenia referred to a national immunodeficiency clinic reveals a B-cell signature resembling common variable immunodeficiency (CVID). J Clin Pathol 73:587\u2013592. https:\/\/doi.org\/10.1136\/jclinpath-2019-206235","journal-title":"J Clin Pathol"},{"key":"1729_CR38","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1111\/acps.13443","volume":"146","author":"S Lim","year":"2022","unstructured":"Lim S, Liew E, Leo A et al (2022) Haematological changes and adverse events associated with BNT162b2 mRNA COVID-19 vaccine in patients receiving clozapine\u2014findings from an audit. Acta Psychiatr Scand 146:179\u2013181. https:\/\/doi.org\/10.1111\/acps.13443","journal-title":"Acta Psychiatr Scand"},{"key":"1729_CR39","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1007\/s002280100375","volume":"57","author":"K Raaska","year":"2001","unstructured":"Raaska K, Raitasuo V, Neuvonen P (2001) Effect of influenza vaccination on serum clozapine and its main metabolite concentrations in patients with schizophrenia. Eur J Clin Pharmacol 57:705\u2013708. https:\/\/doi.org\/10.1007\/s002280100375","journal-title":"Eur J Clin Pharmacol"},{"key":"1729_CR40","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.4682","author":"S Jean","year":"2019","unstructured":"Jean S, Romain L, Florvil S et al (2019) A case of sudden very late onset of severe clozapine-induced agranulocytosis following an influenza vaccine. Cureus. https:\/\/doi.org\/10.7759\/cureus.4682","journal-title":"Cureus"},{"key":"1729_CR41","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1097\/JCP.0000000000001577","volume":"42","author":"M Hansbauer","year":"2022","unstructured":"Hansbauer M, Fastantz E, Lutz J, Hasan A (2022) Myocarditis after clozapine initiation and mRNA SARS-CoV-2 vaccination. J Clin Psychopharmacol 42:502\u2013503. https:\/\/doi.org\/10.1097\/JCP.0000000000001577","journal-title":"J Clin Psychopharmacol"},{"key":"1729_CR42","doi-asserted-by":"publisher","DOI":"10.1503\/jpn.210027","author":"D Thompson","year":"2021","unstructured":"Thompson D, Delorme CM, White RF, Honer WG (2021) Elevated clozapine levels and toxic effects after SARS-CoV-2 vaccination. J Psychiatry Neurosci. https:\/\/doi.org\/10.1503\/jpn.210027","journal-title":"J Psychiatry Neurosci"},{"key":"1729_CR43","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1097\/JCP.0000000000001488","volume":"41","author":"AT Makhlouf","year":"2021","unstructured":"Makhlouf AT, Van Alphen MU, Manzano GS, Freudenreich O (2021) A seizure After COVID-19 vaccination in a patient on clozapine. J Clin Psychopharmacol 41:689\u2013690. https:\/\/doi.org\/10.1097\/JCP.0000000000001488","journal-title":"J Clin Psychopharmacol"},{"key":"1729_CR44","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1002\/npr2.12238","volume":"42","author":"T Imai","year":"2022","unstructured":"Imai T, Ochiai S, Ishimaru T et al (2022) A case report: clozapine-induced leukopenia and neutropenia after mRNA COVID-19 vaccination. Neuropsychopharm Rep 42:238\u2013240. https:\/\/doi.org\/10.1002\/npr2.12238","journal-title":"Neuropsychopharm Rep"},{"key":"1729_CR45","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1097\/JCP.0000000000001527","volume":"42","author":"M Takaki","year":"2022","unstructured":"Takaki M, Yada Y, Sakamoto S et al (2022) A decrease of neutrophils after COVID-19 vaccination in a treatment-resistant patient with schizophrenia taking clozapine. J Clin Psychopharmacol 42:324\u2013325. https:\/\/doi.org\/10.1097\/JCP.0000000000001527","journal-title":"J Clin Psychopharmacol"},{"key":"1729_CR46","doi-asserted-by":"publisher","first-page":"29","DOI":"10.2147\/IMCRJ.S350879","volume":"15","author":"T Tomita","year":"2022","unstructured":"Tomita T, Sakamoto Y, Saito M et al (2022) Two patients with schizophrenia treated with clozapine developed neutropenia after receiving a COVID-19 vaccine. IMCRJ 15:29\u201333. https:\/\/doi.org\/10.2147\/IMCRJ.S350879","journal-title":"IMCRJ"},{"key":"1729_CR47","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1097\/JCP.0000000000001522","volume":"42","author":"C Kn\u00f6chel","year":"2022","unstructured":"Kn\u00f6chel C, Hefner G, Stiehl T, Schmidbauer W (2022) Elevated clozapine blood concentrations after second COVID-19 vaccination with spikevax (COVID-19 vaccine moderna). J Clin Psychopharmacol 42:317\u2013320. https:\/\/doi.org\/10.1097\/JCP.0000000000001522","journal-title":"J Clin Psychopharmacol"},{"key":"1729_CR48","doi-asserted-by":"publisher","DOI":"10.4088\/PCC.22cr03388","author":"O Fournier","year":"2022","unstructured":"Fournier O, Sanders E, Fetter JC (2022) Low COVID-19 immunoglobulin G titers following vaccination and breakthrough infection in patients taking clozapine. Prim Care Compan CNS Disord. https:\/\/doi.org\/10.4088\/PCC.22cr03388","journal-title":"Prim Care Compan CNS Disord"},{"key":"1729_CR49","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1093\/schbul\/sbac148","volume":"49","author":"G Giles","year":"2023","unstructured":"Giles G, Varghese S, Shymko G et al (2023) Clozapine therapy and COVID-19: a systematic review of the prevalence rates, health outcomes, hematological markers, and patient perspectives. Schizophr Bull 49:53\u201367. https:\/\/doi.org\/10.1093\/schbul\/sbac148","journal-title":"Schizophr Bull"},{"key":"1729_CR50","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1080\/15622975.2021.2013095","volume":"23","author":"N Bonkat","year":"2022","unstructured":"Bonkat N, Fellendorf FT, Dalkner N, Reininghaus EZ (2022) Severe mental disorders and vaccinations\u2014a systematic review. World J Biol Psychiatry 23:501\u2013516. https:\/\/doi.org\/10.1080\/15622975.2021.2013095","journal-title":"World J Biol Psychiatry"},{"key":"1729_CR51","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1136\/bmjebm-2017-110853","volume":"23","author":"MH Murad","year":"2018","unstructured":"Murad MH, Sultan S, Haffar S, Bazerbachi F (2018) Methodological quality and synthesis of case series and case reports. BMJ EBM 23:60\u201363. https:\/\/doi.org\/10.1136\/bmjebm-2017-110853","journal-title":"BMJ EBM"},{"key":"1729_CR52","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1002\/j.2051-5545.2011.tb00014.x","volume":"10","author":"M De Hert","year":"2011","unstructured":"De Hert M, Correll CU, Bobes J et al (2011) Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care. World Psychiatry 10:52\u201377. https:\/\/doi.org\/10.1002\/j.2051-5545.2011.tb00014.x","journal-title":"World Psychiatry"},{"key":"1729_CR53","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1001\/jama.284.20.2606","volume":"284","author":"K Lasser","year":"2000","unstructured":"Lasser K, Boyd JW, Woolhandler S et al (2000) Smoking and mental illness: a population-based prevalence study. JAMA 284:2606. https:\/\/doi.org\/10.1001\/jama.284.20.2606","journal-title":"JAMA"},{"key":"1729_CR54","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jsmc.2014.11.009","volume":"10","author":"MJ Murphy","year":"2015","unstructured":"Murphy MJ, Peterson MJ (2015) Sleep disturbances in depression. Sleep Med Clin 10:17\u201323. https:\/\/doi.org\/10.1016\/j.jsmc.2014.11.009","journal-title":"Sleep Med Clin"},{"key":"1729_CR55","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1016\/S0140-6736(19)32316-5","volume":"394","author":"O Plana-Ripoll","year":"2019","unstructured":"Plana-Ripoll O, Pedersen CB, Agerbo E et al (2019) A comprehensive analysis of mortality-related health metrics associated with mental disorders: a nationwide, register-based cohort study. The Lancet 394:1827\u20131835. https:\/\/doi.org\/10.1016\/S0140-6736(19)32316-5","journal-title":"The Lancet"},{"key":"1729_CR56","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.amepre.2022.09.002","volume":"64","author":"J Gao","year":"2023","unstructured":"Gao J, Feng L, Li Y et al (2023) A systematic review and meta-analysis of the association between SARS-CoV-2 vaccination and myocarditis or pericarditis. Am J Prev Med 64:275\u2013284. https:\/\/doi.org\/10.1016\/j.amepre.2022.09.002","journal-title":"Am J Prev Med"},{"key":"1729_CR57","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1111\/acps.13398","volume":"145","author":"M Vickers","year":"2022","unstructured":"Vickers M, Ramineni V, Malacova E et al (2022) Risk factors for clozapine-induced myocarditis and cardiomyopathy: a systematic review and meta-analysis. Acta Psychiatr Scand 145:442\u2013455. https:\/\/doi.org\/10.1111\/acps.13398","journal-title":"Acta Psychiatr Scand"}],"container-title":["European Archives of Psychiatry and Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00406-023-01729-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00406-023-01729-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00406-023-01729-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T06:06:04Z","timestamp":1738735564000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00406-023-01729-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,2]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["1729"],"URL":"https:\/\/doi.org\/10.1007\/s00406-023-01729-0","relation":{},"ISSN":["0940-1334","1433-8491"],"issn-type":[{"value":"0940-1334","type":"print"},{"value":"1433-8491","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,2]]},"assertion":[{"value":"11 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"W. Strube has received a speaker's honorarium from Mag & More GmbH and neurocare and was a member of the advisory board of Recordati. E. Wagner has been invited to advisory boards from Recordati. A. Hasan has received speakership fees from Lundbeck, Otsuka, Janssen and Recordati and was the member of advisory boards for these companies as well as for ROVI. All other authors report no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}